The Importance of Testing as Staff Return to the Office
The Importance of Testing as Staff Return to the Office
29 April 2021
The ongoing pandemic continues to impact daily life. COVID-19 has changed how we socialise, work – whether from home or from the office – and furthermore our daily routines. Even with the easing of restrictions, we will all have to live with a ‘new normal’ for quite some time.
COVID-19 has altered the way which we consume, and drugs and alcohol are no exception. The closure of pubs and restaurants have meant that supermarket and off-licenses have seen alcohol sales soar due to drinking from home being the main way to consume alcohol. Drug consumption has been affected, with supply chains being impacted due to lockdowns & limitations on travel distances.
Some studies have begun to emerge; which highlight how consumption trends have changed since COVID-19 begun.
Below are some of the key findings:
Returning to Work?
The reason for highlighting the above figures is to show how workplace testing for drugs & alcohol shifted dramatically. Whilst for many companies lockdown meant adjusting to working from home, other business sectors continued to operate as normal, including Randox Testing Services. If you are now thinking of returning your staff to the office, Randox Testing Services (RTS) remains open and fully operational and available to carry out testing.
Throughout the COVID-19 pandemic, RTS have continued to provide drug & alcohol testing services. At all times, we have ensured our staff are equipped to provide sensible advice and flexible solutions to drug & alcohol testing.
We have provided each Collection Officer with full PPE to ensure they meet requirements for personal and professional safety. Full social distancing guidelines are always followed whilst conducting testing. We continue to advise and navigate companies through this period as more businesses return to the office and more testing is required.
Importance of testing
The stats mentioned at the top of this article highlight the changing nature of how people have consumed alcohol and drugs over the last 12 months. With increases being seen in both quantity of consumption and frequency, it is important that companies are aware of the potential dangers that may arise if a member of staff arrives to the office intoxicated or under the influence of drugs.
In addition to the alcohol stats, annual research is also carried out to highlight drug consumption patterns. According to research by Public Health England and the devolved nations’ Health Departments, the most recent surveys covering England, Wales and Scotland reported the highest prevalence of drug use in the past 10 years. From the most recent surveys, the prevalence of any drug use in the last year was 9.4% in England and Wales, 12% in Scotland, and 5.9% in Northern Ireland.
In September 2020, a report from the European Monitoring Centre for Drugs and Drug Addiction said Scotland had the highest recorded drug death rate in Europe, far ahead of Sweden in second place. More than 1,200 people in Scotland died of drug misuse in 2019.
In April 2021, a report from Alliance Health Alcohol stated that more the 80 people in the UK die every day because of alcohol-related causes.
The consumption of drugs & alcohol in these uncertain times can cause untold potential dangers for employers. With staff working from home for over a year, many may have turned to alcohol more than what they intended.
Contact us today and speak with our experts who will provide more information about how testing works and the ways in which RTS can help your company if you are returning to the office.
E-mail: testingservices@randox.com
Phone: +44 (0) 28 9445 1011
For those who’ve beaten addiction in their own lives Rehab 4 Addiction is a free addiction helpline. Click here.
Want to know more?
Contact us or visit our website to read more.
Record level of alcohol deaths recorded during COVID-19 pandemic
Record level of alcohol deaths recorded during COVID-19 pandemic
22 March 2021
Deaths caused by alcohol consumption hit a new high during the first nine months of 2020, new figures for England and Wales show.
Between January and September, 5,640 deaths were registered with this cause – an increase of 16% on the same period in 2019. This significant increase has been the highest recorded figure since records began in 2001. The high rates spanned the period during and after the first national COVID-19 lockdown, according to new figures from the Office for National Statistics.
As in past years, rates of male alcohol-specific deaths were twice those seen for women. Experts say the coronavirus pandemic will have had little effect on how the data was gathered and recorded. But it is not clear how much it may have contributed to the deaths.
A spokesman for ONS said:
“Today’s data shows that in the first three quarters of 2020, alcohol-specific deaths in England and Wales reached the highest level since the beginning of our data series, with April to September, during and after the first lockdown, seeing higher rates compared to the same period in previous years.”
“The reasons for this are complex and it will take time before the impact the COVID-19 pandemic has had on alcohol-specific deaths is fully understood.”
Effects of Alcohol
Alcohol’s impact on your body starts from the moment of consumption. While an occasional glass of wine or beer isn’t a cause for concern, the cumulative effects of drinking beer, wine or spirits can take its toll.
Excessive consumption can impact various parts of the body. Effects can range from weakening of the immune and digestive system, to inflammation and sugar level issues.
Our ‘Effects Of’ Series provides a range of educational posters that ca be displayed in workplaces. Click here to view them.
Did you know that alcohol misuse at work can:
Breath Testing in the Workplace
Handheld breathalysers are an ideal device for conducting workplace alcohol testing. Quick and easy testing provides an instant readout of the donor’s breath alcohol measurement. Simply compare the reading to the cutoff defined in your own drug and alcohol testing policy.
Breathalyser devices gauge blood alcohol content (BAC) by measuring deep lung air. This type of testing can accurately determine whether a person has recently consumed alcohol or is currently over the legal or pre-determined limit. Breathalyser calibrations are maintained in accordance with the manufacturers specifications and periodically accuracy checked to ensure results are accurate and reliable.
How Randox Testing Services can help
At Randox Testing Services, we are pleased to offer a range of stand-alone alcohol tests or combinations of tests to meet your needs.
Throughout the COVID-19 pandemic, RTS have continued to provide drug & alcohol testing services. At all times, we have ensured our staff are equipped to provide sensible advice and flexible solutions to drug & alcohol testing.
Whether for use in workplace settings or for use in court proceedings for medico-legal cases, our range of alcohol testing methods will provide you with accurate and reliable results at competitive prices.
For more information on our alcohol testing services, or to request a quote, contact us using any of the below details.
Website: www.randoxtestingservices.com
Email: testingservices@randox.com
Phone: +44 (0) 28 9445 1011
For those who’ve beaten addiction in their own lives Rehab 4 Addiction is a free addiction helpline. Click here.
Want to know more?
Contact us or visit our website to read more.
The Impact of Coronavirus on Drug Use in Europe
15 March 2021: Impact of Coronavirus on Drug Use in Europe
The effect of COVID-19 on the consumption of drugs in Europe has been varied depending on the drug type concerned. Overall, 51.6% of participants in a survey have increased their drug or alcohol consumption and 57.3% reported taking drugs more frequently. The main explanations for these inclines are due to boredom and anxiety, likely due to the imposed restrictions of strict lockdown measures.
According to Statista, Cannabis remains to be the most popular drug used within Europe as 27.2% of respondents revealed that they have used the drug in their lifetime compared to only 5.4% using cocaine. Since the COVID-19 pandemic began in March 2020, regular users of Cannabis have increased their usage, however it is important to note that this has only affected 10% of respondents.
There has been a major hold on the party lifestyle with the shut-down of nightclubs and lack of festival events. As well as, a decrease in the supply of readily available drugs on the market resulting from transport restrictions at country borders. This has impacted the usage of recreational drugs such as cocaine, LSD and MDMA which have seen a decline. The Global Drug Survey revealed that 40% of respondents have used these drugs less during the pandemic.
This detrimental trend has resulted in the domestic production of synthetic opioids. There is a very high risk that substitutes such as fentanyl will become more common. This prediction is concerning due to the dangers associated with such drugs leading to addiction and overdoses. For instance, fentanyl compared to heroin is 50 times stronger.
Public Health England has also released a warning relating to the rise in illegally produced prescription drugs sold as benzodiazepines. These cause harmful health issues due to the mix of unsafe and unknown components.
Randox Toxicology
Randox Toxicology are helping to fight drug trafficking by continually investing in new technologies to aid in the rapid and large-scale screening for drugs of abuse. We are world leaders in drug screening solutions with the capability of detecting over 500 drug and drug metabolites using our innovative Biochip Array Technology – the most comprehensive on the drug testing market. Our patented Biochip Array Technology works across a variety of matrices including whole blood, urine, oral fluid, meconium, vitreous humor and hair.
Using our revolutionary Biochip Array Technology, the Evidence MultiSTAT is a fully automated benchtop analyser that enables onsite, simultaneous testing for up to 21 classical, synthetic or prescription drugs from a single sample in under 20 minutes. This quick and highly reliable technology makes it perfect for use in non-laboratory settings for people with no lab experience.
To find out more about our Biochip Array Technology and our Evidence Series range of analysers, visit www.randoxtoxicology.com or email info@randoxtoxicology.com
For those who’ve beaten addiction in their own lives Rehab 4 Addiction is a free addiction helpline. Click here.
Randox Toxicology Products and Services
BIOCHIP
EVIDENCE
ELISA
MATRICES
Want to know more about Randox?
Contact us or visit our homepage to view more.
Record Seizure of Synthetic Drugs in Spain: A Randox Toxicology Blog
05 February 2021: Record Seizure of Synthetic Drugs in Spain
In a record seizure of synthetic drugs for Spain, police have confiscated approximately 827,000 ecstasy tablets, 76kg of speed, 39.5kg of crystal meth and 217 litres of liquid amphetamine at the start of 2021.
Eleven people – from Spain, the Netherlands, Romania, Colombia and Italy – were arrested during a joint investigation by the Guardia Civil and national police forces, according to a statement. The police operation, which lasted nearly a year, resulted in the largest synthetic drugs seizure in Spain, and second-largest ecstasy seizure in Europe over the past 20 years.
The criminal organisation was described as “the most important criminal organisation dedicated to the manufacture and trafficking of synthetic drugs in the history of Spanish drug trafficking”.
Once the large haul was in Spain, the drugs were planned to be processed in two laboratories set up in Barcelona.
“It’s worth noting that of all the substances seized, the 217 litres of liquid amphetamine would – had it been processed in the organisation’s Barcelona laboratories – have produced 738kg of speed, making it the biggest ever amphetamine seizure in Spain,” a statement said.
Randox Toxicology
Randox Toxicology are helping to fight drug trafficking by continually investing in new technologies to aid in the rapid and large-scale screening for drugs of abuse. We are world leaders in drug screening solutions with the capability of detecting over 500 drug and drug metabolites using our innovative Biochip Array Technology – the most comprehensive on the drug testing market. Our patented Biochip Array Technology works across a variety of matrices including whole blood, urine, oral fluid, meconium, vitreous humor and hair.
Using our revolutionary Biochip Array Technology, the Evidence MultiSTAT is a fully automated benchtop analyser that enables onsite, simultaneous testing for up to 21 classical, synthetic or prescription drugs from a single sample in under 20 minutes. This quick and highly reliable technology makes it perfect for use in non-laboratory settings for people with no lab experience.
To find out more about our Biochip Array Technology and our Evidence Series range of analysers, visit www.randoxtoxicology.com or email info@randoxtoxicology.com
For those who’ve beaten addiction in their own lives Rehab 4 Addiction is a free addiction helpline. Click here.
Randox Toxicology Products and Services
BIOCHIP
EVIDENCE
ELISA
MATRICES
Want to know more about Randox?
Contact us or visit our homepage to view more.
The importance of drug and alcohol testing in uncertain times
The importance of drug and alcohol testing in uncertain times
01 February 2021
The ongoing pandemic has had a dramatic impact on daily life. COVID-19 has changed how we socialise, work and go about our daily routines. If infections continue to rise, we will all have to live with ongoing restrictions in some form or another for quite some time.
COVID-19 has altered the way which we consume, and drugs & alcohol are no exception. The closure of pubs and restaurants have meant that supermarket and off-licenses have seen alcohol sales soar due to drinking from home being the main way to consumer alcohol. Drug consumption has been affected, with supply chains being impacted due to lockdowns & limit on travel distances.
New studies have begun to emerge which highlight how consumption trends in relation to alcohol specifically have changed since COVID-19 begun.
Below are some of the key findings:
- The Royal College of Psychiatrists analysed Public Health England data to reveal that over 8.4 million people are now drinking at a higher risk level – rising from 4.8 million in February; a 75% increase.
- Data from the Commission on Alcohol Harms and the Alcohol Health Alliance revealed that alcohol sales rose by 67% before lockdown began.
- An interim report from the Global Drug Survey (GDS) in early June revealed that COVID-19 and the ensuing lockdown have changed people’s drinking habit.
- 47% of Britons who drink stated that they had been drinking earlier in the day since lockdown started – a figure that was higher than for most other nations included in the survey.
- In addition, over 50% of Britons revealed that they had increased the number of days on which they drink, with a third of British respondents also reporting an increase in binge drinking.
- Alcohol Change commissioned a study that looked at drinking consumptions during lockdown in England.
- One in five drinkers (21%) said they have been drinking more frequently since the lockdown. This equates to around 8.6 million UK adults who may be drinking more frequently.
- 15% of those surveyed also said they have been drinking more per session since lockdown.
Business As Usual
The reason for highlighting the above figures is to show that, whilst for many lockdown meant adjusting to working from home, others business sectors continued to operate as normal. As such, workplace testing for drugs & alcohol shifted dramatically. Many companies who had a testing policy in place that included random testing suddenly stopped due to staff being based at home. However, other key sectors such as construction, manufacturing, logistics all continued to function. With these businesses continuing, Randox Testing Services (RTS) remains open and fully operational and available to carry out testing.
Michelle Fenn, Business Development Manager for RTS, commented on the changing testing trends that occurred;
“RTS continue to operate and provide full-service provision during the on-going pandemic. During the first lockdown we noticed a change in testing, as more companies operated on a work from home basis. However, for some this isn’t possible and have had to maintain operations. Due to circumstances, we have seen companies increase pre-employment testing as new staff are brought on to cope with changing workplace demands. Other testing programmes have been altered such as random testing, but we continue to provide full services and are meeting & often exceeding requirements by our customers.”
Throughout the COVID-19 pandemic, RTS have continued to provide drug & alcohol testing services. At all times, we have ensured our staff are equipped to provide sensible advice and flexible solutions to drug & alcohol testing.
We have provided each Collection Officer with full PPE to ensure they meet requirements for personal and professional safety. Full social distancing guidelines are always followed whilst conducting testing. We continue to advise and navigate companies through this period as more businesses return and testing is required.
Importance of testing
The stats mentioned at the top of this article highlight the changing nature of how people have consumed alcohol over the last 12 months. With increases being seen in both quantity of consumption and frequency, it is important that companies are aware of the potential dangers that may arise if a member of staff arrives to work intoxicated or under the influence of drugs.
In addition to the alcohol stats, annual research is also carried out to highlight drug consumption patterns. According to research by Public Health England and the devolved nations Health Departments, the most recent surveys covering England, Wales and Scotland reported the highest prevalence of drug use in the past 10 years. From the most recent surveys, the prevalence of any drug use in the last year was 9.4% in England and Wales, 12% in Scotland, and 5.9% in Northern Ireland.
In September 2020, a report from the European Monitoring Centre for Drugs and Drug Addiction said Scotland had the highest recorded drug death rate in Europe, far ahead of Sweden in second place. More than 1,200 people in Scotland died of drug misuse in 2019.
The consumption of drugs & alcohol in these uncertain times can cause untold potential dangers for employers. Whilst many companies will continue to function with staff working remotely, for some this isn’t possible.
Safety-critical industries such as construction, manufacturing and logistics will have staff present who need to carry on with daily tasks. It is important to ensure that staff are always safe, this includes provision of testing for drugs & alcohol.
Risk of injury
Employers put in place multiple mechanisms to ensure accidents at work do not occur. Despite these efforts, it’s not always possible to remove the danger. In the UK, workplace injury amounted to £5.2 billion in costs/damages in 2017/18.
28.2 million working days were lost due to work-related ill health and non-fatal workplace injuries in 2018/19. Furthermore, the construction, retail/wholesale, manufacturing, accommodation and agriculture had statistically higher rate of workplace injury per 100,000 workers according to the Labour Force Survey 2018/19.
These statistics highlight the dangers of accidents occurring in the workplace. With the potential for serious injury or worst-case scenario a fatal incident, it is of paramount importance to ensure employees are safe in the knowledge that accidents will not occur due to substance misuse or employees being under the influence.
Fully managed testing service
Randox Testing Services specialise in drug and alcohol testing for workplaces. We provide a quality service that covers all employer needs with the safety of employees at the centre of this focus.
Our experience in the industry and the knowledge of our parent company Randox Laboratories has allowed us to pivot our offering to provide fully compliant and safe COVID-19 testing for workplaces. In these uncertain times, COVID-19 can cause potentially devastating consequences if not correctly managed and addressed.
A new study by researchers at University College London revealed that 86% of people who tested positive for COVID-19 did not have symptoms, highlighting the importance of frequent screening to reduce spread of the virus.
Our COVID-19 test uses Real-Time PCR to accurately detect for the virus. With our knowledge & expertise in testing for workplace companies, we are proud to offer this service; with our test currently used as part of the Government’s National Testing Programme.
The service includes a range of different options, each designed to meet the needs of any business and their requirements. From a fully managed service where our trained and full PPE equipped Collection Officers will conduct testing on behalf of your company, to our mobile testing unit which can move to multiple sites and conduct large volume testing with results in less than three hours, we are confident our services can meet your needs. By using any of our testing services for COVID-19, you can provide peace of mind to employees by conducing regular testing or get your employees back to work as part of a return to work programme.
About Randox Testing Services
We specialise in testing. Whether that be for drugs & alcohol or COVID-19, we are confident that no matter what your testing needs, we will be able to fully understand your requirements and successfully help your company to reduce the impact of drugs & alcohol or COVID-19.
Employees are a company’s greatest asset. Therefore, it is important to ensure they are not exposed to any dangers such as someone potentially intoxicated from drug & alcohol consumption. RTS can help eradicate this danger, whilst helping your employees successfully understand how to mitigate the impacts of substance misuse, through managed testing programme and a range of training & education services to inform and educate staff.
Contact us today and speak with our experts who will provide more information about how testing works and the ways in which RTS can help your company.
E-mail: testingservices@randox.com
Phone: +44 (0) 28 9445 1011
Web: www.randoxtestingservices.com
For those who’ve beaten addiction in their own lives Rehab 4 Addiction is a free addiction helpline. Click here.
Want to know more?
Contact us or visit our website to read more.
U.S. Drug Overdose Deaths Resurge to Record During the Pandemic
22 October 2020: U.S. Drug Overdose Deaths Resurge to Record During the Pandemic
Drug overdose deaths in the USA rose to a record high in 2019, after falling for the first time for 25 years in 2018. Almost 72,000 people died from drug overdoses in 2019 according to the preliminary data that was released by the Centres for Disease Control and Prevention earlier this year.
Though there is currently no hard data available, there is speculation that the pandemic is complicating and worsening the surge, as 2020 looks to be even more devastating than 2019. Data collected by The New York Times saw for the first half of 2020 drug overdose deaths have risen by an average of 13 percent across America compared to last year. If this trend continues into the rest of the year, it will be the sharpest rise in annual drug deaths since 2016, when fentanyl made its way into US drug trafficking and street supply.
Increased funding toward addiction treatment, prevision and recovery services did shows signs of improving overdose deaths. Though the government has made this positive headway in the last few years in how they tackle the drug epidemic in America, this progress could be threatened by the current COVID-19 pandemic.
Earlier in the month, Brett Giroir, the administration’s assistant secretary for health, said in a statement, “We understand that there is an extraordinary amount of work to do, especially now as we are also dealing with the Covid-19 pandemic that could markedly affect our nation’s mental health and risk of substance use.”
Several public health experts said conditions created by the pandemic could hurt the nation’s fragile progress in fighting the surge of drug deaths but noted that the overdose rate was on its way back up well before the virus arrived. “Covid just makes it a bit worse,” said Dr. Dan Ciccarone, a professor of medicine at the University of California, San Francisco, who studies the opioid epidemic. “It’s a small wave riding on top of a tsunami that continues to devastate.”
Although official statistics on 2020 overdose deaths won’t be available for a long time, there is local evidence showing drug related deaths are rising into 2020.
Increase in Drug related deaths from 2019 through the first portion of 2020
Though a lot of this data precedes the coronavirus pandemic, researchers believe there are several reasons why the virus could worsen the trend.
When state lockdowns first began in March, Dr. Anna Lembke, a clinician with Stanford’s Addiction Medicine Dual Diagnosis Clinic, noticed many of her patients showing signs of improving. “Many patients described a kind of peacefulness without the constant hubbub of modern life and the constant triggers they’re exposed to,” she said.
However, in response to the virus, the US government has done something unheard-of: it relaxed rules and regulations around prescribing methadone and buprenorphine, two commonly prescribed opioid addiction treatments. Patients no longer needed to attend daily in person appointments to receive their methadone prescriptions and could instead be given 4 weeks’ worth at a time. Doctors no longer need to meet in person to prescribe buprenorphine.
This was initially celebrated as a positive change, however as the pandemic has progressed and people have remained isolated, lockdown has become harmful to people with mental health issues and drug addiction disorders.
“Social isolation has always been a huge component of drug overdose risk,” said Traci Green, an epidemiologist at Brown University who studies drug abuse and addiction. “So much of what we’ve been trying to do has been completely unravelled.”
Experts have pointed to other dangers lockdown poses such as;
- Lack of revival fall back from other users due to an increase in solo drug users
- Less emotional support as in person visits are scaled back
- Inconsistent drug strength and quality
- Supply or income disruption leading to inconsistent drug use habits and accidental overdose
Randox Toxicology
Using our revolutionary Biochip Array Technology, the Evidence MultiSTAT is a fully automated benchtop analyser that enables onsite, simultaneous testing for up to 21 classical, synthetic or prescription drugs from a single sample in under 20 minutes. This quick and highly reliable technology makes it perfect for use in hospitals and medical centres, as pressure increases with the rising number of drug overdose deaths in the US.
Randox Toxicology Products and Services
BIOCHIP
EVIDENCE
ELISA
MATRICES
Want to know more about Randox?
Contact us or visit our homepage to view more.
Alcohol consumption during the COVID-19 pandemic
09 July 2020
Alcohol consumption during the COVID-19 pandemic
Alcohol consumption during the COVID-19 pandemic
On 31 December 2019, the Wuhan Municipal Health Commission in Wuhan City, Hubei province, China, reported a cluster of 27 pneumonia cases (including seven severe cases) of unknown aetiology, with a common reported link to Wuhan’s Huanan Seafood Wholesale Market, a wholesale fish and live animal market. On 23 January 2020, Wuhan City was locked down – with all travel in and out of Wuhan prohibited –and movement inside the city was restricted.
By March, the World Health Organisation (WHO) declared COVID-19 a global pandemic, with more than 150 countries worldwide being affected. Many countries, including the UK; imposed stringent public health measures that included the closure of businesses & strict social distancing guidelines.
Due to the enforced lockdown, many within the UK workforce had to make alternative working arrangements, with working from home becoming the new norm. With the closure of businesses and the hospitality sector including bars and restaurants, it meant people seeking alternative means to purchase and consume alcohol.
Before the pandemic, alcohol was attributed to being a financial burden to the UK health system and wider economy. The British Medical Journal estimated that alcohol costs the NHS more than £3.5 billion and the wider economy at least £21bn each year.
The organisation Alcohol Change UK commissioned new research to look at whether people’s drinking habits changed during the COVID-19 lockdown. Over 2,000 people completed the survey, with results weighted to ensure they were representative of the UK population.
The key takeaway from the report is people are consuming alcohol differently because of the lockdown. Around one in five drinkers (21%) told us that they have been drinking more frequently since the lockdown. This suggests that around 8.6 million UK adults are drinking more frequently under lockdown.
Furthermore, while almost half of drinkers said they were drinking about the same amount on a typical drinking day, 15% said they have been drinking more per session since lockdown.
The Global Drug Survey produced a special report for COVID-19 with more than 80,000 participants. The report stated that 44% of those who participated said the frequency of alcohol use increased. Reasons for this included ‘having more time to drink and feeling bored more often.’ However, 25.5% reported having decreased their use of alcohol during COVID-19.
As restrictions begin to ease and more people return to work, it is important to highlight the impact of COVI-19 on the workforce. People’s way of life has changed dramatically, with this change comes different ways of consuming alcohol. It is important to note that the figures above are a proportionate representation based on those who took part, but valuable insights can be gained when looking at alcohol use. For employers who have staff returning to work, their safety is of paramount importance. This will include effectively managing substance misuse, should it be an issue in the workplace.
Effects of Alcohol
Alcohol’s impact on your body starts from the moment you take your first sip. While an occasional glass of wine or beer isn’t a cause for concern, the cumulative effects of drinking wine, beer, or spirits can take its toll.
Consumption of alcohol can impact various parts of the body. Effects can range from weakening of the immune and digestive system, to inflammation and sugar level issues.
Our ‘Effects Of’ Series provides educational posters that can be displayed in workplaces to highlight the dangers of alcohol. Click here for more information.
About Randox Testing Services
Randox Testing Services are a specialist in the workplace drug & alcohol testing sector. We provide a wide range of testing for companies who want to reduce the impact of substance misuse in the workplace. With a range of service options and expert staff on hand to provide help and training, our services will help to eradicate the impact of drugs and alcohol.
Throughout the COVID-19 pandemic, RTS have continued to provide drug & alcohol testing services. At all times, we have ensured our staff are equipped to provide sensible advice and flexible solutions to drug & alcohol testing.
We have provided each Collection Officer with full PPE to ensure they meet requirements for personal and professional safety. Full social distancing guidelines are followed at all times when possible whilst conducting testing. We will continue to advise and navigate companies through this period as more businesses return and testing is required.
If you have any questions regarding drug & alcohol testing, contact us today.
Web: www.randoxtestingservices.com
Email: testingservices@randox.com
Phone: +44 (0) 28 9445 1011
Want to know more?
Contact us or visit our website to read more.
